Ym. Jin et al., MITOGENIC PROPERTIES OF UKRAIN (NSC-6315170) ON HUMAN PERIPHERAL-BLOOD MONOCYTES - CLINICAL IMPLICATIONS, Drugs under experimental and clinical research, 22(3-5), 1996, pp. 99-101
Using a cell-proliferation assay the authors examined and compared the
mitogenic effects of Ukrain and phytohaemagglutinin (PHA) on human pe
ripheral blood mononuclear cells (PBMCs), as well as their synergic ef
fects. II was found that even a short period of pretreatment of the ce
ll with Ukrain had a potent synergic effect on PHA mitogenesis resulti
ng in significantly higher cell stimulation indices than those of PHA
alone. Moreover it was found that a short period of PHA treatment of t
he cells is almost imperative for Ukrain to exert its mitogenic effect
s. The mitogenic effect of Ukrain on human PBMCs is consistent with a
previous clinical report which found that circulating lymphocytes were
significantly increased in cancer patients treated with Ukrain. Thus
the in vitro assay used in these studies may serve as a prognostic ass
ay for potential patient responsiveness to Ukrain treatment as well as
a clinical parameter during Ukrain therapy.